InfanDx AG Reports Successful Validation of Biomarker Panels for the Early Detection of Hypoxic Ischemic Encephalopathy
October 12, 2022 05:00 ET
|
AKAMPION
Numerous metabolic biomarkers identified in AAMBI study confirmed in BANON cohortPanel sensitivities of up to 89% at specificities of up to 93% in blinded validation study Formal IVD development of...
ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors
October 04, 2022 04:00 ET
|
AKAMPION
- Seasoned immuno-oncology executive brings significant medical and biopharma expertise Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD, USA – October 4, 2022 – ImmunOs Therapeutics...
TolerogenixX Publishes Three-Year Follow-Up Data from Phase I Trial of Immune Tolerance-Inducing MIC-Lx Cell Therapy
September 26, 2022 04:00 ET
|
AKAMPION
Publication in high-impact Journal of the American Society of NephrologyResults pave the way for a novel cell therapy in organ transplantation Heidelberg, September 26, 2022 – TolerogenixX...
InfanDx AG ernennt Nicole Witzmann zum Finanzvorstand
September 01, 2022 05:00 ET
|
AKAMPION
- Corporate Finance Expertin mit mehr als acht Jahren Erfahrung im Gesundheitssektor Köln/Berlin, Deutschland, und Boston, USA, 01. September 2022 - Die InfanDx AG, ein privates...
InfanDx AG Appoints Nicole Witzmann as Chief Financial Officer
September 01, 2022 05:00 ET
|
AKAMPION
Seasoned professional with more than 8 years of healthcare corporate finance experience Cologne/Berlin, Germany, and Boston, MA, USA, September 01, 2022 – InfanDx AG, a privately held...
BellaSeno Starts Two Clinical Trials of its Resorbable Breast and Chest Implants
August 04, 2022 04:00 ET
|
AKAMPION
Resorbable implants to treat pectus excavatum and silicone breast implant revision / congenital defect correctionFirst patients treated in Australia Leipzig, Germany, August 4, 2022 – BellaSeno...
ELITechGroup und InfanDx AG kooperieren bei der Entwicklung und Herstellung des HypoxE® Neonatal-Tests für klinische Labore
July 27, 2022 04:00 ET
|
AKAMPION
HypoxE® Test ermöglicht die Früherkennung von hypoxisch-ischemischer Enzephalopathie (HIE), bedingt durch Sauerstoffmangel bei der GeburtELITechGroup übernimmt Auftragsentwicklung und -herstellung von...
ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories
July 27, 2022 04:00 ET
|
AKAMPION
HypoxE® Test allows for the early detection of Hypoxic-Ischemic Encephalopathy (HIE) caused by lack of oxygen during birthELITechGroup to provide contract development and manufacturing services for...
ImmunOs Therapeutics schließt Serie B Finanzierung in Höhe von US $74 Millionen ab
June 07, 2022 01:30 ET
|
AKAMPION
- Samsara, Lightspeed, Gimv und Mission BioCapital stärken als neue Anteilseigner das Investorenkonsortium und erweitern die transatlantische Präsenz - Unternehmen gründet US-Niederlassung zum...
ImmunOs Therapeutics Raises $74 Million Series B Financing Round
June 07, 2022 01:30 ET
|
AKAMPION
- New investors Samsara, Lightspeed, Gimv, and Mission BioCapital further strengthen investor base and expand transatlantic footprint - Company establishes U.S. subsidiary to accelerate...